<DOC>
	<DOCNO>NCT02871635</DOCNO>
	<brief_summary>Primary Objective : The primary objective trial compare clinical efficacy BI 695501 EU-approved Humira® patient active Crohn 's disease ( CD ) . Secondary Objectives : The secondary objective trial compare efficacy safety BI 695501 EU-approved Humira® across induction maintenance phase .</brief_summary>
	<brief_title>BI 695501 Versus Humira Patients With Active Crohn 's Disease : Trial Comparing Efficacy , Endoscopic Improvement , Safety , Immunogenicity</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Inclusion criterion : Males female age &gt; =18 = &lt; 80 year Screening diagnosis moderate severely active Crohn 's Disease ( CD ) , confirm endoscopy radiologic evaluation , 4 month evidence mucosal ulceration . Patients must follow : Crohn 's Disease Activity Index ( CDAI ) score &gt; =220 = &lt; 450 A diagnosis Crohn 's Disease ( CD ) confirm ileocolonoscopy Screening Endoscopic documentation ulceration Screening correspond score 2 3 least one five segment colon Ulcerated Surface subscore Simple Endoscopic Score Crohn 's Disease ( SESCD ) Antitumor necrosis factor ( TNF ) naïve patient patient previously treat infliximab anti TNF agent ( except adalimumab ) initially respond meet one follow criterion : Responded developed secondary resistance due confirm antiinfliximab antidrug antibody formation , cause infliximab depletion Responded become intolerant Further inclusion criterion apply Exclusion criterion : Patients ulcerative colitis indeterminate colitis Patients symptomatic know obstructive stricture Surgical bowel resection perform within 6 month prior Screening plan resection time enrol trial Patients ostomy ileoanal pouch Patients short bowel syndrome Patients previously use infliximab never clinically respond Patients previously receive treatment adalimumab , participate adalimumab adalimumab biosimilar clinical trial , positive antiadalimumab antibody baseline Further exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>